142 related articles for article (PubMed ID: 35704991)
21. Costs for Breast Cancer Care in the Military Health System: An Analysis by Benefit Type and Care Source.
Eaglehouse YL; Manjelievskaia J; Shao S; Brown D; Hofmann K; Richard P; Shriver CD; Zhu K
Mil Med; 2018 Nov; 183(11-12):e500-e508. PubMed ID: 29660010
[TBL] [Abstract][Full Text] [Related]
22. [Health care costs attributable to tobacco consumption on a national level in the Mexican Social Security Institute].
Reynales-Shigematsu LM; Rodríguez-Bolaños Rde L; Jiménez JA; Juárez-Márquez SA; Castro-Ríos A; Hernández-Avila M
Salud Publica Mex; 2006; 48 Suppl 1():S48-64. PubMed ID: 17684689
[TBL] [Abstract][Full Text] [Related]
23. Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States.
Schwartz KL; Simon MS; Bylsma LC; Ruterbusch JJ; Beebe-Dimmer JL; Schultz NM; Flanders SC; Barlev A; Fryzek JP; Quek RGW
Cancer; 2018 May; 124(10):2104-2114. PubMed ID: 29505670
[TBL] [Abstract][Full Text] [Related]
24. An evaluation of the healthcare costs associated with adverse events in patients with breast cancer.
Wang LC; Chen HM; Chen JH; Lin YC; Ko Y
Int J Health Plann Manage; 2021 Sep; 36(5):1465-1475. PubMed ID: 33914358
[TBL] [Abstract][Full Text] [Related]
25. Direct medical and non-medical costs of a one-year care pathway for early operable breast cancer: Results of a French multicenter prospective study.
Héquet D; Huchon C; Soilly AL; Asselain B; Berseneff H; Trichot C; Combes A; Alves K; Nguyen T; Rouzier R; Baffert S
PLoS One; 2019; 14(7):e0210917. PubMed ID: 31291250
[TBL] [Abstract][Full Text] [Related]
26. [Standard treatment cost of female breast cancer at different TNM stages].
Li H; Huang Y; Huang R; Li JY
Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):946-50. PubMed ID: 24506967
[TBL] [Abstract][Full Text] [Related]
27. Direct medical costs for partial refractory epilepsy in Mexico.
García-Contreras F; Constantino-Casas P; Castro-Ríos A; Nevárez-Sida A; Estrada Correa Gdel C; Carlos Rivera F; Guzmán-Caniupan J; Torres-Arreola Ldel P; Contreras-Hernández I; Mould-Quevedo J; Garduño-Espinosa J
Arch Med Res; 2006 Apr; 37(3):376-83. PubMed ID: 16513488
[TBL] [Abstract][Full Text] [Related]
28. Cost of treatment for breast cancer in central Vietnam.
Hoang Lan N; Laohasiriwong W; Stewart JF; Tung ND; Coyte PC
Glob Health Action; 2013 Feb; 6():18872. PubMed ID: 23394855
[TBL] [Abstract][Full Text] [Related]
29. [Treatment patterns in advanced breast cancer with anthracycline and taxanes and their costs in three public hospitals of Mexico].
Silva JA; Gonzalez JF; Bargalló JE; Hernández-Rivera G; Gómez-Roel X; Rangel S; Vargas-Valencia JJ; Martínez-Fonseca J; Donato BM; Juárez-García A
Value Health; 2011; 14(5 Suppl 1):S147-50. PubMed ID: 21839890
[TBL] [Abstract][Full Text] [Related]
30. Melanoma costs: a dynamic model comparing estimated overall costs of various clinical stages.
Alexandrescu DT
Dermatol Online J; 2009 Nov; 15(11):1. PubMed ID: 19951637
[TBL] [Abstract][Full Text] [Related]
31. Cost-Efficiency of Breast Cancer Care in the US Military Health System: An Economic Evaluation in Direct and Purchased Care.
Eaglehouse YL; Georg MW; Richard P; Shriver CD; Zhu K
Mil Med; 2019 Oct; 184(9-10):e494-e501. PubMed ID: 30839064
[TBL] [Abstract][Full Text] [Related]
32. The addition of neoadjuvant pertuzumab for the treatment of HER2+ breast cancer: a cost estimate with real-world data.
Borges A; Pereira F; Redondo P; Antunes L; Vieira C; Antunes P; Bento MJ; Sousa S; Lopes JM; Rocha-Gonçalves F; de Sousa JA; Pereira DS; Borges M
Health Econ Rev; 2021 Sep; 11(1):33. PubMed ID: 34505956
[TBL] [Abstract][Full Text] [Related]
33. A retrospective analysis of health care costs for bone fractures in women with early-stage breast carcinoma.
Zhou Z; Redaelli A; Johnell O; Willke RJ; Massimini G
Cancer; 2004 Feb; 100(3):507-17. PubMed ID: 14745866
[TBL] [Abstract][Full Text] [Related]
34. Direct medical costs of end-stage kidney disease and renal replacement therapy: a cohort study in Guangzhou City, southern China.
Zhang H; Zhang C; Zhu S; Ye H; Zhang D
BMC Health Serv Res; 2020 Feb; 20(1):122. PubMed ID: 32059726
[TBL] [Abstract][Full Text] [Related]
35. Epilepsy-Related Direct Medical and Direct Non-Medical Cost in Adult Patients Living with Epilepsy at a Tertiary Neurology Center in Rwanda.
Teuwen DE; Sebera F; Murekeyiteto A; Garrez I; Sanchez-Iriso E; Umwiringirwa J; Umuhoza G; Boon PAJM; Dedeken P
Clinicoecon Outcomes Res; 2023; 15():15-27. PubMed ID: 36660476
[TBL] [Abstract][Full Text] [Related]
36. Healthcare costs associated with breast cancer in Germany: a claims data analysis.
Kreis K; Plöthner M; Schmidt T; Seufert R; Schreeb K; Jahndel V; Maas S; Kuhlmann A; Zeidler J; Schramm A
Eur J Health Econ; 2020 Apr; 21(3):451-464. PubMed ID: 31897812
[TBL] [Abstract][Full Text] [Related]
37. Economic evaluation of the breast cancer screening programme in the Basque Country: retrospective cost-effectiveness and budget impact analysis.
Arrospide A; Rue M; van Ravesteyn NT; Comas M; Soto-Gordoa M; Sarriugarte G; Mar J
BMC Cancer; 2016 Jun; 16():344. PubMed ID: 27251556
[TBL] [Abstract][Full Text] [Related]
38. Economic burden of renal cell carcinoma among older adults in the targeted therapy era.
Kale HP; Mays DP; Nadpara PA; Slattum PW; Paul AK; Carroll NV
Urol Oncol; 2019 Jun; 37(6):356.e19-356.e28. PubMed ID: 30846388
[TBL] [Abstract][Full Text] [Related]
39. A cost-benefit analysis of the Mexican Social Security Administration's family planning program.
Nortman DL; Halvas J; Rabago A
Stud Fam Plann; 1986; 17(1):1-6. PubMed ID: 3083537
[TBL] [Abstract][Full Text] [Related]
40. Economic Evaluations of Breast Cancer Care in Low- and Middle-Income Countries: A Scoping Review.
Erfani P; Bhangdia K; Stauber C; Mugunga JC; Pace LE; Fadelu T
Oncologist; 2021 Aug; 26(8):e1406-e1417. PubMed ID: 34050590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
